The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) includes a variety of histological conditions (ranging from liver steatosis and steatohepatitis, to fibrosis and hepatocarcinoma) that are characterized by an increased fat content within the liver. The accumulation/deposition of fat within the liver is essential for diagnosis of NAFLD and might be associated with alterations in the hepatic and systemic inflammatory state. Although it is still unclear if each histological entity represents a different disease or rather steps of the same disease, inflammatory processes in NAFLD might influence its pathophysiology and prognosis. In particular, non-alcoholic steatohepatitis (the most inflamed condition in NAFLDs, which more frequently evolves towards chronic and serious liver diseases) is characterized by a marked activation of inflammatory cells and the upregulation of several soluble inflammatory mediators. Among several mediators, cytokines and chemokines might play a pivotal active role in NAFLD and are considered as potential therapeutic targets. In this review, we will update evidence from both basic research and clinical studies on the potential role of cytokines and chemokines in the pathophysiology of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 948
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Monocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Tumor Necrosis Factor, Other Cytokines and Disease
Tracey, K. J., & Cerami, A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001533 · Cited by 783
Crespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Wu, H., Ghosh, S., Perrard, X. D., Feng, L., Garcia, G. E., Perrard, J. L., Sweeney, J. F., Peterson, L. E., Chan, L., Smith, C. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.638379 · Cited by 680
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Rollins, B. J. (1997) · PubMed · Cited by 603
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., & Taylor, R. (1996) · Diabetes · doi:10.2337/diab.45.7.881 · Cited by 510
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
The role of interleukin-8 in inflammation and mechanisms of regulation.
Bickel, M. (1993) · PubMed · Cited by 468
CCR1 and CCR5 promote hepatic fibrosis in mice
Seki, E., De Minicis, S., Gwak, G.-Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., & Schwabe, R. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37444 · Cited by 431
Adipokines and cytokines in non‐alcoholic fatty liver disease
JARRAR, M. H., BARANOVA, A., COLLANTES, R., RANARD, B., STEPANOVA, M., BENNETT, C., FANG, Y., ELARINY, H., GOODMAN, Z., CHANDHOKE, V., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03586.x · Cited by 430
Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000073313.16135.21 · Cited by 427
Gene expression in human NAFLD
Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., Kiviluoto, T., Laitinen, S., Kolak, M., Fisher, R. M., Hamsten, A., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2008 · Cited by 427
In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L., & Zern, M. A. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2477 · Cited by 415
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
The role of TGFβ1 in initiating hepatic stellate cell activation in vivo
Hellerbrand, C., Stefanovic, B., Giordano, F., Burchardt, E. R., & Brenner, D. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80010-5 · Cited by 393
Association of Low Interleukin-10 Levels with the Metabolic Syndrome in Obese Women
Esposito, K., Pontillo, A., Giugliano, F., Giugliano, G., Marfella, R., Nicoletti, G., & Giugliano, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021437 · Cited by 355
Westerbacka, J., Kolak, M., Kiviluoto, T., Arkkila, P., Sirén, J., Hamsten, A., Fisher, R. M., & Yki-Järvinen, H. (2007) · Diabetes · doi:10.2337/db07-0156 · Cited by 355
Friedman, S. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007105 · Cited by 349
Transforming growth factor β and the liver
Bissell, M. D., Roulot, D., & George, J. (2001) · Hepatology · doi:10.1053/jhep.2001.28457 · Cited by 348
Prevelance of abnormal serum aminotransferase values in overweight and obese adolescents
Strauss, R. S., Barlow, S. E., & Dietz, W. H. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)24645-3 · Cited by 329
Fraser, A., Longnecker, M. P., & Lawlor, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.077 · Cited by 327
Obstfeld, A. E., Sugaru, E., Thearle, M., Francisco, A.-M., Gayet, C., Ginsberg, H. N., Ables, E. V., & Ferrante, A. W. (2010) · Diabetes · doi:10.2337/db09-1403 · Cited by 314
Müller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
Hepatic steatosis in obese Chinese children
Chan, D. F. Y., Li, A. M., Chu, W. C. W., Chan, M. H. M., Wong, E. M. C., Liu, E. K. H., Chan, I. H. S., Yin, J., Lam, C. W. K., Fok, T. F., et al. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802734 · Cited by 297
Bruun, J., Verdich, C., Toubro, S., Astrup, A., & Richelsen, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480535 · Cited by 295
Müller, M., Carter, S., Hofer, M. J., & Campbell, I. L. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01089.x · Cited by 293
Valenti, L., Fracanzani, A. L., Dongiovanni, P., Santorelli, G., Branchi, A., Taioli, E., Fiorelli, G., & Fargion, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.31065 · Cited by 289
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
Milani, S., Herbst, H., Schuppan, D., Stein, H., & Surrenti, C. (1991) · PubMed · Cited by 267
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Berres, M.-L., Koenen, R. R., Rueland, A., Zaldivar, M. M., Heinrichs, D., Sahin, H., Schmitz, P., Streetz, K. L., Berg, T., Gassler, N., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41732 · Cited by 263
Effects of Etanercept in Patients With the Metabolic Syndrome
Bernstein, L. E., Berry, J., Kim, S., Canavan, B., & Grinspoon, S. K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.8.902 · Cited by 257
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 253
Human Hepatic Stellate Cells Express CCR5 and RANTES to Induce Proliferation and Migration
Schwabe, R. F., Bataller, R., & Brenner, D. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2003 · Cited by 252
Bertola, A., Bonnafous, S., Anty, R., Patouraux, S., Saint-Paul, M.-C., Iannelli, A., Gugenheim, J., Barr, J., Mato, J. M., Le Marchand-Brustel, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013577 · Cited by 240
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
Wobser, H., Dorn, C., Weiss, T. S., Amann, T., Bollheimer, C., Büttner, R., Schölmerich, J., & Hellerbrand, C. (2009) · Cell Research · doi:10.1038/cr.2009.73 · Cited by 238
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4773 · Cited by 225
Yu, X., Dluz, S., Graves, D. T., Zhang, L., Antoniades, H. N., Hollander, W., Prusty, S., Valente, A. J., Schwartz, C. J., & Sonenshein, G. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6953 · Cited by 220
Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis
Abiru, S., Migita, K., Maeda, Y., Daikoku, M., Ito, M., Ohata, K., Nagaoka, S., Matsumoto, T., Takii, Y., Kusumoto, K., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01191.x · Cited by 209
Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice
Blindenbacher, A., Wang, X., Langer, I., Savino, R., Terracciano, L., & Heim, M. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50378 · Cited by 202
Klein, C., Wüstefeld, T., Assmus, U., Roskams, T., Rose-John, S., Müller, M., Manns, M. P., Ernst, M., & Trautwein, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523640 · Cited by 200
Predictors of non-alcoholic fatty liver disease in obese children
Sartorio, A., Del Col, A., Agosti, F., Mazzilli, G., Bellentani, S., Tiribelli, C., & Bedogni, G. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602588 · Cited by 183
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
Cintra, D. E., Pauli, J. R., Araújo, E. P., Moraes, J. C., de Souza, C. T., Milanski, M., Morari, J., Gambero, A., Saad, M. J., & Velloso, L. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.017 · Cited by 182
Tumor Necrosis Factor- in Sera of Obese Patients: Fall with Weight Loss
Dandona, P. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2907 · Cited by 176
Transforming growth factor-β gene expression in normal and fibrotic rat liver
De Bleser, P. J., Niki, T., Rogiers, V., & Geerts, A. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80257-7 · Cited by 169
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Wasmuth, H. E., Lammert, F., Zaldivar, M. M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M.-L., Zimmermann, H., Streetz, K. L., Tacke, F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.053 · Cited by 168
El-Assal, O. N., Hong, F., Kim, W., Radaeva, S., & Gao, B. (2004) · PubMed · Cited by 148
Montecucco, F., Braunersreuther, V., Lenglet, S., Delattre, B. M. A., Pelli, G., Buatois, V., Guilhot, F., Galan, K., Vuilleumier, N., Ferlin, W. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr127 · Cited by 147
Self-citationKoca, S. S., Bahçecioğlu, İ. H., Poyrazoğlu, O. K., Özercan, İ. H., Şahin, K., & Üstündağ, B. (2007) · Inflammation · doi:10.1007/s10753-007-9053-z · Cited by 147
Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice
Tamura, Y., Sugimoto, M., Murayama, T., Ueda, Y., Kanamori, H., Ono, K., Ariyasu, H., Akamizu, T., Kita, T., Yokode, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168633 · Cited by 147
Stärkel, P., Sempoux, C. L., Leclercq, I. A., Hérin, M., Deby, C. M. T., Desager, J., & Horsmans, Y. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00360-x · Cited by 146
Yamaguchi, K., Itoh, Y., Yokomizo, C., Nishimura, T., Niimi, T., Fujii, H., Okanoue, T., & Yoshikawa, T. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.75 · Cited by 143
Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis
Syn, W., Choi, S. S., & Diehl, A. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.003 · Cited by 133
How can transforming growth factor beta be targeted usefully to combat liver fibrosis?
Shek, F., & Benyon, R. C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200402000-00001 · Cited by 131
Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration
Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129
The Role of Cytokines and Chemokines in the Development of Steatohepatitis
Lalor, P. F., Faint, J., Aarbodem, Y., Hübscher, S. G., & Adams, D. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979470 · Cited by 128
Increased transforming growth factor-β1 gene expression in human liver disease
Annoni, G., Weiner, F. R., & Zern, M. Α. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90168-o · Cited by 124
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahçecioğlu, İ. H., Yalnız, M., Ataseven, H., İlhan, A., Özercan, İ. H., Seçkin, D., & Şahin, K. (2005) · PubMed · Cited by 111
Andersen, T., Christoffersen, P., & Gluud, C. N. (1984) · PubMed · Cited by 103
Anticytokine Therapy — A New Era in the Treatment of Rheumatoid Arthritis?
O’Dell, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400411 · Cited by 102
Tamura, Y., Sugimoto, M., Murayama, T., Minami, M., Nishikaze, Y., Ariyasu, H., Akamizu, T., Kita, T., Yokode, M., & Arai, H. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3368 · Cited by 101
Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese
Dixon, J. B., Bhathal, P. S., Jonsson, J. R., Dixon, A. F. R., Powell, E. E., & O’Brien, P. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00459-8 · Cited by 101
IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
Mas, E., Danjoux, M., Garcia, V., Carpentier, S., Ségui, B., & Levade, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007929 · Cited by 95
den Boer, M. A. M., Voshol, P. J., der Elst, J. P. S.-V., Korsheninnikova, E., Ouwens, D. M., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2006) · Endocrinology · doi:10.1210/en.2006-0417 · Cited by 95
Teoh, N., Field, J., & Farrell, G. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.039 · Cited by 92
Non-alcoholic Fatty Liver Disease in Children
Manco, M., Bottazzo, G. F., Vito, R. D., Marcellini, M., Mingrone, G., & Nobili, V. (2008) · touchREVIEWS in Endocrinology · doi:10.1080/07315724.2008.10719744 · Cited by 87
Relationship between nonalcoholic fatty liver disease and metabolic syndrome
Shao Hua, C. H. E. N., He, F., Hua Li, Z. H. O. U., Hong Ru, W. U., Chen, X., & Li, Y. M. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00487.x · Cited by 87
Lee, Y.-M., Sutedja, D. S., Wai, C. T., Dan, Y.-Y., Aung, M., Zhou, L., Cheng, C. L., Wee, A., & Lim, S. G. (2008) · Hepatology International · doi:10.1007/s12072-008-9058-1 · Cited by 78
LESMANA, C. R. A., HASAN, I., BUDIHUSODO, U., GANI, R. A., KRISNUHONI, E., AKBAR, N., & LESMANA, L. A. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00386.x · Cited by 76
Zhou, Y., Li, Y., Nie, Y., Yang, H., Qi, Z., Huang, J. V., Shi, S., Lai, X., & Huang, H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06144.x · Cited by 76
Schrage, A., Wechsung, K., Neumann, K., Schümann, M., Schulzke, J., Engelhardt, B., Zeitz, M., Hamann, A., & Klugewitz, K. (2008) · Hepatology · doi:10.1002/hep.22443 · Cited by 69
Yang, S. J., IglayReger, H. B., Kadouh, H. C., & Bodary, P. F. (2009) · Diabetologia · doi:10.1007/s00125-009-1309-8 · Cited by 64
Angulo, P. (2011) · Hepatology · doi:10.1002/hep.24403 · Cited by 57
Yamaguchi, K., Itoh, Y., Yokomizo, C., Nishimura, T., Niimi, T., Umemura, A., Fujii, H., Okanoue, T., & Yoshikawa, T. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.2 · Cited by 56
Rull, A., Rodríguez, F., Aragonès, G., Marsillach, J., Beltrán‐Debón, R., Alonso‐Villaverde, C., Camps, J., & Joven, J. (2009) · Cytokine · doi:10.1016/j.cyto.2009.08.006 · Cited by 56
Atherogenic diet-induced hepatitis is partially dependent on murine TLR4
Desai, M. S., Mariscalco, M. M., Tawil, A., Vallejo, J. G., & Smith, C. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607390 · Cited by 54
TGF-β in wound healing: a review
Douglas, H. E. (2010) · Journal of Wound Care · doi:10.12968/jowc.2010.19.9.78235 · Cited by 54
Kirovski, G., Gäbele, E., Dorn, C., Moleda, L., Niessen, C., Weiß, T. S., Wobser, H., Schacherer, D., Buechler, C., Wasmuth, H. E., et al. (2010) · PubMed · doi:10.5283/epub.37048 · Cited by 53
Anti-Chemokine Therapy for Inflammatory Diseases
Castellani, M. L., Bhattacharya, K., Tagen, M., Kempuraj, D., Perrella, A., Lutiis, M. A. D., Boucher, W. S., Conti, P., Theoharides, T. C., Cerulli, G. G., et al. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000303 · Cited by 52
Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
Calcaterra, V., AMICI, M. D., Klersy, C., Torre, C., Brizzi, V., Scaglia, F., Albanesi, M., Albertini, R., Allais, B., & Larizza, D. (2009) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 50
Pinto, L. D. F., Compri, C. M., Fornari, J. V., Bartchewsky, W., Cintra, D. E., Trevisan, M. S., Carvalho, P. D. O., Ribeiro, M. L., Velloso, L. A., Saad, M. J. A., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02200.x · Cited by 47
Kassel, K. M., Guo, G. L., Tawfik, O. W., & Luyendyk, J. P. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.143 · Cited by 44
Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Miller, A. M., & McInnes, I. B. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049796 · Cited by 40
Lucero, D., Zago, V., Lopez, G. I., Graffigna, M. N., Fainboim, H. A., Miksztowicz, V., Meroño, T., Belli, S., Levalle, O. A., Wikinski, R. L. W., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.025 · Cited by 38
Tekkarışmaz, N., Özeni̇rler, S., Yücel, A. A., Bukan, N. C., & Erdem, Ö. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701286680 · Cited by 30
Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism
Rull, A., Escolá‐Gil, J. C., Julve, J., Rotllán, N., Calpe‐Berdiel, L., Coll, B., Aragonès, G., Marsillach, J., Alonso‐Villaverde, C., Camps, J., et al. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.08.003 · Cited by 30
Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?
Montecucco, F., & Mach, F. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008786848268 · Cited by 17
Cited by
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Kitade, H., Chen, G., Ni, Y., & Ota, T. (2017) · Nutrients · doi:10.3390/nu9040387 · Cited by 492
Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 453
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Stojsavljević, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18070 · Cited by 325
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Masuoka, H. C., & Chalasani, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12016 · Cited by 283
Metadata
- Authors
- Braunersreuther, V.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 18
- Issue
- 8
- Pages
- 727
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2117941396
- Cited by
- 362
- References
- 110
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.